Skip to content
Home/Companies/Biotech/Botalys
Botalys

Botalys

Biotech·Belgium·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Botalys?

Botalys is a Belgian Biotech company, currently owned by Aliad Venture Capital since 2022.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Aliad Venture Capital
Investor
Aliad Venture Capital
ALIAD · 2013 · VC

Key facts

HQBelgium
SectorBiotech
Websitebotalys.com

More from ALIAD

Other portfolio companies in the same fund.

Suzhou Origin Materials Technology Co., Ltd. (OMT)
Active
China
Ammobia
Active
United States· 2026
Quobly
Quobly
Active
Deep TechFrance· 2026
Noble Gas Systems
Noble Gas Systems
Active
ClimateTechUS· 2025
Power to Hydrogen
Power to Hydrogen
Active
ClimateTechUS· 2024
Distran
Distran
Active
IndustrialsSwitzerland· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Botalys?

Botalys is currently owned by Aliad Venture Capital, through ALIAD, since 2022.

When did Aliad Venture Capital acquire Botalys?

Aliad Venture Capital acquired Botalys in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue